Therapeutic Impact of Gardasil<sup>®</sup> in Recurrent Respiratory Papillomatosis: A Retrospective Study on RRP Patients
<b>Background:</b> Recurrent respiratory papillomatosis (RRP) is a rare, non-malignant disease caused by human papillomavirus (HPV) types 6 and 11. The condition primarily affects the larynx, potentially leading to life-threatening airway obstruction. It is more aggressive in younger pat...
Saved in:
| Main Authors: | Jennifer Sieg, Asita Fazel, Elgar Susanne Quabius, Astrid Dempfle, Susanne Wiegand, Markus Hoffmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/3/321 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis”
by: Olga Ovcinnikova, et al.
Published: (2024-12-01) -
Gardasil® as adjunctive therapy for respiratory papillomatosis at Red Cross Children’s Hospital, Cape Town
by: Shavina Frank, et al.
Published: (2024-05-01) -
Polyadenylated versions of small non-coding RNAs in Saccharomyces cerevisiae are degraded by Rrp6p/Rrp47p independent of the core nuclear exosome
by: Anusha Chaudhuri, et al.
Published: (2024-05-01) -
HPV Vaccination Knowledge and Decision‐Making Among Adults 27 to 45 Years: A Large Online Survey
by: Matthew E. Lin, et al.
Published: (2025-06-01) -
RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
by: Zijian Da, et al.
Published: (2025-06-01)